Vir Biotechnology (VIR)
(Delayed Data from NSDQ)
$8.23 USD
+0.60 (7.86%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $8.22 -0.01 (-0.12%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC5/2/24 |
---|---|
Current Quarter | -0.99 |
EPS Last Quarter | -0.86 |
Last EPS Surprise | 24.56% |
ABR | 1.78 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -4.04 |
Next Year | -3.87 |
EPS (TTM) | -4.59 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 16.07M | 11.55M | 55.28M | 52.38M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 39.40M | 21.30M | 121.80M | 106.20M |
Low Estimate | 6.30M | 6.30M | 25.00M | 26.30M |
Year ago Sales | 62.96M | 3.80M | 86.18M | 55.28M |
Year over Year Growth Est. | -74.48% | 203.82% | -35.86% | -5.24% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.99 | -1.03 | -4.04 | -3.87 |
# of Estimates | 4 | 4 | 6 | 6 |
Most Recent Consensus | -0.99 | -1.08 | -4.19 | -3.81 |
High Estimate | -0.79 | -0.91 | -3.43 | -3.12 |
Low Estimate | -1.18 | -1.23 | -4.94 | -4.60 |
Year ago EPS | -1.06 | -1.45 | -4.59 | -4.04 |
Year over Year Growth Est. | 6.60% | 28.97% | 11.98% | 4.33% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.99 | -1.03 | -4.04 | -3.87 |
7 Days Ago | -0.99 | -1.03 | -4.04 | -3.87 |
30 Days Ago | -0.99 | -1.03 | -4.04 | -3.87 |
60 Days Ago | -0.99 | -1.03 | -4.06 | -3.89 |
90 Days Ago | -1.21 | -1.27 | -4.69 | -4.24 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.99 | -1.03 | -4.04 | -3.87 |
Zacks Consensus Estimate | -0.99 | -1.03 | -4.04 | -3.87 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.86 | -1.22 | -1.45 | -1.06 | NA |
Estimate | -1.14 | -1.21 | -1.21 | -0.81 | NA |
Difference | 0.28 | -0.01 | -0.24 | -0.25 | -0.06 |
Surprise | 24.56% | -0.83% | -19.83% | -30.86% | -6.74% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more